Labels for long-term sample storage
Brady offers 72 combinations of label material and ink
The company has a broad product range that offers 72 different combinations of label material and ink to ensure durability in any storage conditions.
The B461 self-laminating labels, for example, display exceptional durability in liquid nitrogen. A clear over-laminating film covers the white printable area, protecting not only the legend but also allowing users to see the sample itself. These labels are available in different formats to suit all standard laboratory vials, tubes and slides.
Founded in 1914, the Brady Corporation has offices in 24 countries and is represented in over 100. It has research laboratories in the US and Europe to ensure a continuous programme of product innovation and improvement.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
Read moreAs therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
As therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part IV)
Real-time monitoring, digital-first platforms and early scalability planning can help manufacturers to maintain quality, flexibility and speed as dosage forms become more sophisticated
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part III)
Early collaboration, specialist purification and carefully targeted investment help manufacturers to bridge development and commercial production, improving process robustness, efficiency and dependable supply